Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adams Harkness was a prominent Boston-based investment bank that specialized in providing research, brokerage, and investment banking services to emerging growth companies. The firm was particularly well-regarded for its deep expertise in the healthcare, life sciences, and technology sectors. It played a significant role in the mid-market space, helping numerous biotech and medical device companies with initial public offerings and mergers and acquisitions. Known for its high-quality equity research, the firm hosted influential annual conferences that connected institutional investors with emerging industry leaders. In 2005, the firm was acquired by Canaccord Capital to expand its presence in the United States and strengthen its global technology and healthcare practices. Following the acquisition, it was integrated into what is now known as Canaccord Genuity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adams Harkness.